Paul Turner

Safety of live attenuated influenza vaccine in atopic children with egg allergy

M. Erlewyn-Lajeunesse, N. Andrews, M. Snape, 2015, The Journal of allergy and clinical immunology.

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

V. Libri, S. Royal, G. Screaton, 2022, The Lancet Respiratory Medicine.

Multiplex Human Papillomavirus L1L2 virus-like particle antibody binding assay

N. Andrews, S. Beddows, A. Godi, 2022, MethodsX.

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019–2021

C. Murray, S. Oddie, P. Aley, 2022, Archives of Disease in Childhood.

Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine

V. Libri, J. Nguyen-Van-Tam, S. Faust, 2021, Social Science Research Network.

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

V. Libri, G. Screaton, J. Nguyen-Van-Tam, 2023, Journal of Infection.

Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma

G. Roberts, C. Murray, M. Erlewyn-Lajeunesse, 2019, The Journal of allergy and clinical immunology.